Evidence map›Paper›PMID 39224570›Full record

ArticleJBMR plus2024

Sclerotic prostate cancer bone metastasis: woven bone lesions with a twist.

Felipe Eltit, Qiong Wang, Naomi Jung, Sheryl Munshan, Dennis Xie, Samuel Xu, Doris Liang, Bita Mojtahedzadeh, Danmei Liu, Raphaële Charest-Morin and 5 more

Abstract read
In one paragraph

Article in JBMR plus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Bone health in cancer: perspective on the use of osteoanabolic agents.Therapeutic advances in endocrinology and metabolism · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Felipe EltitDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.ORCID https://orcid.org/0000-0001-7941-561X
Qiong WangDepartment of Materials Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Naomi JungDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Sheryl MunshanDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Dennis XieDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Samuel XuDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Doris LiangSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 2B9, Canada.
Bita MojtahedzadehDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Danmei LiuCentre for Aging SMART, Vancouver, BC V5Z 1M9, Canada.
Raphaële Charest-MorinDepartment of Orthopaedics, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Eva CoreyDepartment of Urology, University of Washington, Seattle, WA 98195, United States.
Lawrence D TrueDepartment of Urology, University of Washington, Seattle, WA 98195, United States.
Colm MorrisseyDepartment of Urology, University of Washington, Seattle, WA 98195, United States.
Rizhi WangDepartment of Materials Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Michael E CoxDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.ORCID https://orcid.org/0000-0001-6468-6046

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
Steroid Metabolism in Castration-Resistant Prostate CancerP01CA163227 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PETER S NELSON · 2013 to 2026
$25.0M
NCI NIH HHS P01 CA163227NCI NIH HHS P50 CA097186
6 · The paper itself

Abstract

Bone metastases are the most severe and prevalent consequences of prostate cancer (PC), affecting more than 80% of patients with advanced PC. PCBMs generate pain, pathological fractures, and paralysis. As modern therapies increase survival, more patients are suffering from these catastrophic consequences. Radiographically, PCBMs are predominantly osteosclerotic, but the mechanisms of abnormal bone formation and how this pathological increase in bone density is related to fractures are unclear. In this study, we conducted a comprehensive analysis on a cohort of 76 cadaveric PCBM specimens and 12 cancer-free specimens as controls. We used micro-computed tomography to determine 3D organization and quantify bone characteristics, quantitative backscattering electron microscopy to characterize mineral content and details in bone structure, nanoindentation to determine mechanical properties, and histological and immunohistochemical analysis of bone structure and composition. We define 4 PCBM phenotypes: osteolytic, mixed lytic-sclerotic, and 2 subgroups of osteosclerotic lesions-those with residual trabeculae, and others without residual trabeculae. The osteosclerotic lesions are characterized by the presence of abnormal bone accumulated on trabeculae surfaces and within intertrabecular spaces. This abnormal bone is characterized by higher lacunae density, abnormal lacunae morphology, and irregular lacunae orientation. However, mineral content, hardness, and elastic modulus at micron-scale were indistinguishable between this irregular bone and residual trabeculae. The collagen matrix of this abnormal bone presents with irregular organization and a prominent collagen III composition. These characteristics suggest that osteosclerotic PCBMs initiate new bone deposition as woven bone; however, the lack of subsequent bone remodeling, absence of lamellar bone deposition on its surface, and presence of collagen III distinguish this pathologic matrix from conventional woven bone. Although the mineralized matrix retains normal bone hardness and stiffness properties, the lack of fibril anisotropy presents a compromised trabecular structure, which may have clinical implications.

Indexed as

bone histomorphometry< analysis/quantitation of bonebone QCT/microCT< analysis/quantitation of bonecollagen< bone matrixindentation (nano/micro)< analysis/quantitation of bonetumor-induced bone disease< cancer

Identifiers

PMID39224570
PMCPMC11365963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.